P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY

• Gloria Ines Iacoboni Garcia-Calvo,
• Victor Navarro,
• Ana Africa Martin Lopez,
• Mariana Bastos Oreiro,
• Kai Rejeski,
• Katarzyna Aleksandra Jalowiec,
• Paula Amat,
• Juan Luis Reguera Ortega,
• Viktoria Blumenberg,
• Laura Gallur,
• María Herrero-García,
• Claire Roddie,
• Rebeca Bailen,
• Ana Benzaquen,
• Cecilia Carmen Carpio Segura,
• Lucía López Corral,
• Rafael Hernani,
• MI Kwon,
• Lourdes Martín-Martín,
• Marion Subklewe,
• Maeve O’reilly6,
• Pere Barba Suñol

Affiliations

Gloria Ines Iacoboni Garcia-Calvo

1 Vall d’Hebron University Hospital, Barcelona, Spain

Victor Navarro

2 Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Ana Africa Martin Lopez

3 Hospital Clínico Universitario de Salamanca, Salamanca, Spain

Mariana Bastos Oreiro

4 Hospital General Universitario Gregorio Marañon, Madrid, Spain

Kai Rejeski

5 Department of Medicine III - Hematology/Oncology, Munich, Spain

Katarzyna Aleksandra Jalowiec

6 University College London, London, United Kingdom

Paula Amat

7 Hospital Clinico Universitario, Valencia, Spain

Juan Luis Reguera Ortega

8 Hospital Virgen del Rocío, Sevilla, Spain

Viktoria Blumenberg

5 Department of Medicine III - Hematology/Oncology, Munich, Spain

Laura Gallur

1 Vall d’Hebron University Hospital, Barcelona, Spain

María Herrero-García

9 Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain

Claire Roddie

6 University College London, London, United Kingdom

Rebeca Bailen

4 Hospital General Universitario Gregorio Marañon, Madrid, Spain

Ana Benzaquen

7 Hospital Clinico Universitario, Valencia, Spain

Cecilia Carmen Carpio Segura

1 Vall d’Hebron University Hospital, Barcelona, Spain

Lucía López Corral

3 Hospital Clínico Universitario de Salamanca, Salamanca, Spain

Rafael Hernani

7 Hospital Clinico Universitario, Valencia, Spain

MI Kwon

4 Hospital General Universitario Gregorio Marañon, Madrid, Spain

Lourdes Martín-Martín

9 Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL), and Department of Medicine and Cytometry Service, University of Salamanca (USAL), Salamanca, Spain

Marion Subklewe

5 Department of Medicine III - Hematology/Oncology, Munich, Spain

Maeve O’reilly6

1 Vall d’Hebron University Hospital, Barcelona, Spain

Pere Barba Suñol

1 Vall d’Hebron University Hospital, Barcelona, Spain